𝔖 Bobbio Scriptorium

✦ LIBER ✦

Limits of lipid-lowering therapy: the potential benefits of amlodipine as an antiatherosclerotic agent

✍ Scribed by D.M Kramsch

Book ID: 117355263
Publisher: Elsevier Science
Year: 1997
Tongue: English
Weight: 55 KB
Volume: 62
Category: Article
ISSN: 0167-5273
DOI: 10.1016/s0167-5273(97)00249-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Overcoming the limitations of maximal li

Overcoming the limitations of maximal lipid lowering in preventing atherosclerosis progression by an anti-oxidant Ca2+-antagonist (amlodipine)

✍ Kramsch, D.M.; Sharma, R.C.; Lai, M. 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 296 KB

Emerging Applications of Argatroban in t

Emerging Applications of Argatroban in the Management of Systemic Malignancies: Potential Benefits Besides Its Primary Role as an Antithrombin Agent

✍ Kapoor, S. 📂 Article 📅 2013 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 398 KB

Cost-effectiveness of Chlorthalidone, Am

Cost-effectiveness of Chlorthalidone, Amlodipine, and Lisinopril as First-step Treatment for Patients with Hypertension: An Analysis of the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

✍ Paul A. Heidenreich; Barry R. Davis; Jeffrey A. Cutler; Curt D. Furberg; David R 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 227 KB

Baseline Low-Density Lipoprotein Cholest

Baseline Low-Density Lipoprotein Cholesterol Is an Important Predictor of the Benefit of Intensive Lipid-Lowering Therapy: A PROVE IT–TIMI 22 (Pravastatin or Atorvastatin Evaluation and Infection Therapy–Thrombolysis In Myocardial Infarction 22) Analysis

✍ Roberto R. Giraldez; Robert P. Giugliano; Satishkumar Mohanavelu; Sabina A. Murp 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 366 KB